Determination of thromboxane formation, soluble CD40L release and thrombopoietin clearance in apheresis platelet concentrates

References

• AuBuchon JP, Herschel L, Roger J, Murphy S. Preliminary validation of a new standard of efficacy for stored platelets. Transfusion 2004; 44: 36–41
   PubMedGoogle Scholar
• Holme S, Heaton WA, Courtright M. Platelet storage lesion in second-generation containers: Correlation with platelet ATP levels. Vox Sang 1987; 53: 214–220
   PubMed Web of Science ®Google Scholar
• Murphy S, Rebulla P, Bertolini F, Holme S, Moroff G, Snyder E, Stromberg R. In vitro assessment of the quality of stored platelet concentrates. The BEST (Biomedical Excellence for Safer Transfusion) Task Force of the International Society of Blood Transfusion. Transfus Med Rev 1994; 8: 29–36
   PubMedGoogle Scholar
• Seghatchian J, Krailadsiri P. The platelet storage lesion. Transfus Med Rev 1997; 11: 130–144
   PubMed Web of Science ®Google Scholar
• Kunicki TJ, Tuccelli M, Becker GA, Aster RH. A study of variables affecting the quality of platelets stored at “room temperature”. Transfusion 1975; 15: 414–421
   PubMed Web of Science ®Google Scholar
• Kostelijk EH, Fijnheer R, Nieuwenhuis HK, Gouwerok CW, de Korte D. Soluble P-selectin as parameter for platelet activation during storage. Thromb Haemost 1996; 76: 1086–1089
   PubMed Web of Science ®Google Scholar
• Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of in vitro platelet assays: The tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Transfusion 1998; 38: 31–40
   PubMed Web of Science ®Google Scholar
• Bertolini F, Murphy S. A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion. Transfusion 1996; 36: 128–132
   PubMed Web of Science ®Google Scholar
• Schonbeck U, Mach F, Libby P. CD154 (CD40 ligand). Int J Biochem Cell Biol 2000; 32: 687–693
   PubMedGoogle Scholar
• Hermann A, Rauch BH, Braun M, Schror K, Weber AA. Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets 2001; 12: 74–82
   PubMed Web of Science ®Google Scholar
• Reinboldt S, Wenzel F, Rauch BH, Hohlfeld T, Grandoch M, Fischer JW, Weber AA. Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets. Platelets 2009; 20: 441–444
   PubMed Web of Science ®Google Scholar
• Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: The switch-hitting player of cardiovascular disease. Circulation 2002; 106: 896–899
   PubMed Web of Science ®Google Scholar
• Wenzel F, Baertl A, Zimmermann N, Hohlfeld T, Giers G, Oldenburg J, Assert R. Different behaviour of soluble CD40L concentrations can be reflected by variations of preanalytical conditions. Clin Hemorheol Microcirc 2008; 39: 417–422
   PubMedGoogle Scholar
• Cognasse F, Boussoulade F, Chavarin P, Acquart S, Fabrigli P, Lamy B, Garraud O. Release of potential immunomodulatory factors during platelet storage. Transfusion 2006; 46: 1184–1189
   PubMed Web of Science ®Google Scholar
• Kaufman J, Spinelli SL, Schultz E, Blumberg N, Phipps RP. Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. J Thromb Haemost 2007; 5: 788–796
   PubMed Web of Science ®Google Scholar
• Wenzel F, Günther W, Baertl A, Lasshofer R, Rox J, Fischer JC, Giers G. Comparison of soluble CD40L concentrations and release capacities in apheresis and prestorage pooled platelet concentrates. Clin Hemorheol Microcirc. 2011; 47(4)269–278
   PubMedGoogle Scholar
• Kaushansky K. Thrombopoietin. N Engl J Med 1998; 339: 746–754
   PubMed Web of Science ®Google Scholar
• Wenzel F, Giers G. Identification of reduced serum thrombopoietin concentrations in patients with chronic hepatitis C undergoing an interferon therapy. Clin Chem Lab Med 2010; 48: 1191–1192
   PubMedGoogle Scholar
• Wenzel F, Gruber W, Giers G. Alteration of serum thrombopoietin levels in patients with chronic hepatitis C under interferon therapy. Clin Hemorheol Microcirc 2010; 44: 137–144
   PubMedGoogle Scholar
• Broudy VC, Kaushansky K. Thrombopoietin, the c-mpl ligand, is a major regulator of platelet production. J Leukoc Biol 1995; 57: 719–725
   PubMed Web of Science ®Google Scholar
• Fielder PJ, Hass P, Nagel M, Stefanich E, Widmer R, Bennett GL, Keller GA, de Sauvage FJ, Eaton D. Human platelets as a model for the binding and degradation of thrombopoietin. Blood 1997; 89: 2782–2788
   PubMed Web of Science ®Google Scholar
• Schror K, Seidel H. Blood-vessel wall arachidonate metabolism and its pharmacological modification in a new in vitro assay system. Naunyn Schmiedebergs Arch Pharmacol 1988; 337: 177–182
   PubMedGoogle Scholar
• Chew M, Rahman M, Ihrman L, Erson A, Zhang S, Thorlacius H. Soluble CD40L (CD154) is increased in patients with shock. Inflamm Res 2010; 59: 979–982
   PubMedGoogle Scholar
• Wang ZY, Shi JM, Han Y, Wang YC, Ruan CG. Comparative study of platelet activation markers in diabetes mellitus patients complicated by cerebrovascular disease. Blood Coagul Fibrinolysis 2001; 12: 531–537
   PubMedGoogle Scholar
• Jelkmann W. The role of the liver in the production of thrombopoietin compared with erythropoietin. Eur J Gastroenterol Hepatol 2001; 13: 791–801
   PubMed Web of Science ®Google Scholar
• Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M, Fiocchi C. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003; 52: 1435–1441
   PubMed Web of Science ®Google Scholar
• Cognasse F, Osselaer JC, Garraud O. Platelets cytokines and their effects on platelet transfusion. Transfus Clin Biol 2007; 14: 69–78
   PubMedGoogle Scholar
• Kazes I, Elalamy I, Sraer JD, Hatmi M, Nguyen G. Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: Involvement in MMP2 activation and platelet aggregation. Blood 2000; 96: 3064–3069
   PubMed Web of Science ®Google Scholar
• Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski MW. Release of gelatinase A during platelet activation mediates aggregation. Nature 1997; 386: 616–619
   PubMed Web of Science ®Google Scholar
• Prasad KS, Andre P, He M, Bao M, Manganello J, Phillips DR. Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc Nat Acad Sci USA 2003; 100: 12367–12371
   PubMed Web of Science ®Google Scholar
• Böck M, Glaser A, Pfosser A, Schleuning M, Heim MU, Mempel W. Storage of single-donor platelet concentrates: Metabolic and functional changes. Transfusion 1993; 33: 311–315
   PubMedGoogle Scholar
• Hamid MA, Kunicki TJ, Aster RH. Lipid composition of freshly prepared and stored platelet concentrates. Blood 1980; 55: 124–130
   PubMedGoogle Scholar
• Cesar JM, Navarro JL. Arachidonic acid metabolism in platelets stored for 5 days. Br J Haematol 1990; 74: 295–299
   PubMedGoogle Scholar
• Weyrich AS, Schwertz H, Kraiss LW, Zimmerman GA. Protein synthesis by platelets: Historical and new perspectives. J Thromb Haemost 2009; 7: 241–246
   PubMed Web of Science ®Google Scholar
• Garner SF, Jones CI, Stephens J, Burns P, Walton J, Bernard A, Angenent W, Ouwehand WH, Goodall AH. Apheresis donors and platelet function: Inherent platelet responsiveness influences platelet quality. Transfusion 2008; 48: 673–680
   PubMedGoogle Scholar
• Holme S. Storage and quality assessment of platelets. Vox Sang 1998; 74(Suppl. 2)207–216
   PubMedGoogle Scholar
• Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995; 85: 2720–2730
   PubMed Web of Science ®Google Scholar
• Li J, Xia Y, Kuter DJ. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: Binding, internalization, stability and pharmacokinetics. Br J Haematol 1999; 106: 345–356
   PubMed Web of Science ®Google Scholar
• Holme S, Heaton A. In vitro platelet ageing at 22 degrees C is reduced compared to in vivo ageing at 37 degrees C. Br J Haematol 1995; 91: 212–218
   PubMed Web of Science ®Google Scholar
• Curvers J, van Pampus EC, Feijge MA, Rombout-Sestrienkova E, Giesen PL, Heemskerk JW. Decreased responsiveness and development of activation markers of PLTs stored in plasma. Transfusion 2004; 44: 49–58
   PubMed Web of Science ®Google Scholar